Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer

Sophie J. Deharvengt(Dartmouth College), Murray Korc(University of California, Irvine)

PLoS ONE

June 27, 2012

10.1371/journal.pone.0039684

Cited by 26

Related Papers

Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.

|PubMed|2001|292

microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions

|Oncogene|2013|153

Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma

|Cell Death and Disease|2015|126

DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

|PLoS ONE|2011|83

DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine

|PLoS ONE|2014|69